CORC

浏览/检索结果: 共5条,第1-5条 帮助

已选(0)清除 条数/页:   排序方式:
Prognostic and predictive value of the novel classification of lung adenocarcinoma in patients with stage IB 期刊论文
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2016, 卷号: 142, 期号: 9
作者:  Luo, Jizhuang;  Huang, Qingyuan;  Wang, Rui;  Han, Baohui;  Zhang, Jie
收藏  |  浏览/下载:10/0  |  提交时间:2019/12/13
A MULTICENTER, RANDOMIZED, OPEN-LABEL, PHASE II TRIAL OF ERLOTINIBVERSUS ETOPOSIDEPLUS CISPLATINWITH CONCURRENT RADIOTHERAPY IN UNRESECTABLESTAGE III NON-SMALLCELL LUNG CANCER (NSCLC) WITH ACTIVATING MUTATION OF EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) IN EXON 19 OR 21(RECEL, ML28545, NCT01714908) 会议论文
作者:  Xing, Ligang;  Zhuo, Minglei;  Wang, Lvhua;  Chen, Ming;  Ma, Shenglin
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/19
A multicenter, randomized, openlabel, phase ii trial of erlotinibversus etoposideplus cisplatinwith concurrent radiotherapy in unresectablestage iii non-smallcell lung cancer (NSCLC) with activating mutation of epidermal growth factor receptor (EGFR) in exon 19 or 21(recel, ml28545, nct01714908) 期刊论文
Journal of Thoracic Oncology, 2013
作者:  Xing L., Zhuo M., Wang L., Chen M., Ma S., Xia T., Fu X., Yu J., Lu Y.
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/19
A MULTICENTER, RANDOMIZED, OPEN-LABEL, PHASE II TRIAL OF ERLOTINIBVERSUS ETOPOSIDEPLUS CISPLATINWITH CONCURRENT RADIOTHERAPY IN UNRESECTABLESTAGE III NON-SMALLCELL LUNG CANCER (NSCLC) WITH ACTIVATING MUTATION OF EPIDERMAL GROWTH FACTOR RECEPTOR ( 期刊论文
2013, 卷号: 8, 页码: S559-S560
作者:  Xing, Ligang;  Zhuo, Minglei;  Wang, Lvhua;  Chen, Ming;  Ma, Shenglin
收藏  |  浏览/下载:6/0  |  提交时间:2020/01/13
艾迪联合紫杉醇和顺铂治疗晚期非小细胞肺癌的meta分析 期刊论文
中国肺癌杂志, 2010, 卷号: 13, 期号: 11, 页码: 1027-1034
作者:  王权;  何曦冉;  田金徽;  汪小刚;  茹沛帆
收藏  |  浏览/下载:3/0  |  提交时间:2016/09/09


©版权所有 ©2017 CSpace - Powered by CSpace